Kaposi sarcoma

E Cesarman, B Damania, SE Krown, J Martin… - Nature reviews Disease …, 2019‏ - nature.com
Kaposi sarcoma (KS) gained public attention as an AIDS-defining malignancy; its
appearance on the skin was a highly stigmatizing sign of HIV infection during the height of …

Diagnosis and treatment of Kaposi sarcoma

JW Schneider, DP Dittmer - American journal of clinical dermatology, 2017‏ - Springer
Kaposi sarcoma (KS) is the most common neoplasm of people living with HIV today. In Sub-
Saharan Africa, KS is among the most common cancers in men, overall. Not only HIV …

B cells are associated with survival and immunotherapy response in sarcoma

F Petitprez, A de Reyniès, EZ Keung, TWW Chen… - Nature, 2020‏ - nature.com
Soft-tissue sarcomas represent a heterogeneous group of cancer, with more than 50
histological subtypes,. The clinical presentation of patients with different subtypes is often …

[HTML][HTML] Advances in immune checkpoint inhibitors for bone sarcoma therapy

P Thanindratarn, DC Dean, SD Nelson… - Journal of bone …, 2019‏ - Elsevier
Bone sarcomas are a collection of sporadic malignancies of mesenchymal origin. The most
common subtypes include osteosarcoma, Ewing sarcoma, chondrosarcoma, and chordoma …

A Newly Established Cuproptosis‐Associated Long Non‐Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft …

J Han, Y Hu, S Liu, J Jiang, H Wang - Journal of oncology, 2022‏ - Wiley Online Library
Cuproptosis, a new type of programmed cell death, is involved in the development and
progression of malignancies. The study of cuproptosis‐associated long non‐coding RNAs …

Biology of bone sarcomas and new therapeutic developments

HK Brown, K Schiavone, F Gouin, MF Heymann… - Calcified tissue …, 2018‏ - Springer
Bone sarcomas are tumours belonging to the family of mesenchymal tumours and constitute
a highly heterogeneous tumour group. The three main bone sarcomas are osteosarcoma …

PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse

B Zheng, T Ren, Y Huang, K Sun, S Wang… - Journal of hematology & …, 2018‏ - Springer
Background Immune checkpoint inhibitors have led to a breakthrough in solid tumor
immunotherapy, but related studies on musculoskeletal tumors are few, especially for PD …

Pediatric cancer immunotherapy: opportunities and challenges

MF Wedekind, NL Denton, CY Chen, TP Cripe - Pediatric Drugs, 2018‏ - Springer
Cancer immunotherapies, widely heralded as transformational for many adult cancer
patients, are becoming viable options for selected subsets of pediatric cancer patients. Many …

Kaposi sarcoma updates

SA Etemad, AK Dewan - Dermatologic clinics, 2019‏ - derm.theclinics.com
KS, with its distinct clinical variants, presents a unique challenge for clinical care. The advent
of ART in the mid-1990s was a major advance in the treatment of AIDS KS, and the …

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas

AR Dancsok, N Setsu, D Gao, JY Blay, D Thomas… - Modern …, 2019‏ - nature.com
Despite advances in our understanding of the underlying molecular drivers of sarcomas, few
treatments are available with proven benefit for advanced metastatic sarcomas …